tiprankstipranks
Oramed Pharmaceuticals (ORMP)
NASDAQ:ORMP
US Market
ORMP
Oramed Pharm
RESEARCH TOOLSreports

Oramed Pharm (ORMP) Financial Statements

529 Followers

Oramed Pharm Financial Overview

Oramed Pharm's market cap is currently $142.78M. The company's EPS TTM is $0; its P/E ratio is 1.57; Oramed Pharm is scheduled to report earnings on January 8, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Sep 23Dec 22Aug 21
Income Statement
Total Revenue$ 2.00M$ 0.00$ 1.34M$ 2.70M$ 2.70M
Gross Profit$ 13.00K$ -193.00K$ 1.34M$ 2.70M$ 2.70M
Operating Income$ -15.09M$ -12.78M$ -15.77M$ -40.60M$ -24.22M
EBITDA$ -15.09M$ -14.87M$ 7.32M$ -36.98M$ -25.04M
Net Income$ 75.32M$ -19.10M$ 5.53M$ -37.76M$ -22.24M
Balance Sheet
Cash & Short-Term Investments$ 51.36M$ 141.93M$ 162.05M$ 155.72M$ 94.14M
Total Assets$ 97.59M$ 155.28M$ 220.55M$ 161.64M$ 128.00M
Total Debt$ 825.00K$ 372.00K$ 51.62M$ 894.00K$ 533.00K
Net Debt$ -45.12M$ -54.05M$ 42.57M$ -39.57M$ -76.71M
Total Liabilities$ 12.03M$ 9.93M$ 57.66M$ 10.49M$ 11.48M
Stockholders' Equity$ 199.74M$ 146.26M$ 163.82M$ 151.81M$ 115.77M
Cash Flow
Free Cash Flow$ -9.15M$ -8.43M$ -10.55M$ -29.20M$ -21.56M
Operating Cash Flow$ -9.14M$ -8.41M$ -10.29M$ -28.70M$ -21.18M
Investing Cash Flow$ 5.44M$ 105.82M$ -73.04M$ 30.21M$ -22.26M
Financing Cash Flow$ -4.74M$ -52.04M$ 51.98M$ 11.56M$ 101.39M
Currency in USD

Oramed Pharm Earnings and Revenue History

Income Statement >

Oramed Pharm Debt to Assets

Balance Sheet >

Oramed Pharm Cash Flow

Cash Flow >

Oramed Pharm Forecast EPS vs Actual EPS

Earnings >